 |
인쇄하기
취소
|
Multinational companies to strengthen R&D in Korea
Multinational pharmaceutical firms are expected to strengthen research and development (R&D) capability in Korea in cooperation with local research institutes to step up studies in related fields.
Key officials from Novartis, Merck, Eli Lilly, Boehringer Ingelheim and AstraZeneca participated in the 3rd BIO KOREA convention, which was held from October 8th to 10th at Osong Bio-Technopolis.
...
Key officials from Novartis, Merck, Eli Lilly, Boehringer Ingelheim and AstraZeneca participated in the 3rd BIO KOREA convention, which was held from October 8th to 10th at Osong Bio-Technopolis.
...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.